Reliance Pharma Fund - Direct (G)

Fund Class : Equity - Pharma
Fund House : Reliance Mutual Fund
Aum(Rs Cr) : 653.56
NAV 27 Apr 2017 135.13 -1.56
(-1.14%)

NAV High-Low (in Rs)

ONE Mth 1444.86
1444.86
52-WEEk 1444.86
1615.51

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes - - - - 14.63
Sensex 1.88 1.73 7.08 16.85 32.2
Nifty 2.02 2.23 7.71 18.56 37.61

Fund Features

Types of Scheme Growth
Options Equity
Assets Size (Rs in Cr) 653.56 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Sailesh Raj Bhan

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 1.00.

Fund Activity

   As On 31 Mar 2017
Category Share (%)
CBLO 0.53
Equity 99.57
› More
   As On 31 Mar 2017
Sector Name Amount
Finance & Investments 4.28
Healthcare 5.94
Miscellaneous 6.45
NA 0.53
Pharmaceuticals - Indian - Bulk Drugs 13.72
Pharmaceuticals - Indian - Bulk Drugs & Formln 52.25
Pharmaceuticals - Multinational 16.93
› More
   As On 31 Mar 2017
Company Name
Cadila Health. 9.79
Aurobindo Pharma 9.58
Abbott India 8.69
Sanofi India 8.24
Sun Pharma.Inds. 8.10
Dr Reddy's Labs 7.30
Lupin 7.00
Cipla 6.98
› More

Fund DETAILS

Asset Management Co.

Registered Address

Reliance Capital Asset Management Company,

One Indiabulls Centre Tower 1
12th Flr 841 Senapati Bapat
Marg Elphinstone Road Mumbai-400013

Phone: 022-30994600 | Fax: 022-30994699

Email: customer_care@reliancemutual.com

Website: www.reliancemutual.com